Last updated: August 9, 2025
Introduction
Denmark Patent DK1791542 pertains to a medicinal invention, with its legal status, scope, and claim breadth holding significance for stakeholders in pharmaceutical R&D, licensing, and competitive intelligence. This analysis dissects the patent's claims, scope, and positioning within the broader pharmaceutical patent landscape, offering insights critical for strategic decision-making.
Patent Overview and Context
DK1791542 was filed to secure intellectual property protection in Denmark, typically aligned with a European or international filing. The patent likely relates to a novel pharmaceutical compound, formulation, or method of use, as indicated by its classification within medicinal or chemical patent classifications. The associated patent family and its jurisdictional coverage greatly influence its commercial scope, enforceability, and value.
Scope and Claims Analysis of DK1791542
1. Patent Classifications and Focus
While precise classification codes are not provided here, drugs patents generally fall under classifications such as:
- A61K: Preparations for medical, dental, or hygienic purposes
- C07D: Heterocyclic compounds
- A61P: Specific methods of treatment
The scope of DK1791542 likely targets a pharmaceutical entity—either a compound, a combination, or a method of using the compound for specific indications.
2. Main Claim Features
The primary claims are expected to define:
- The chemical structure or chemical class of the active ingredient
- Method of preparation or synthesis procedures
- Therapeutic use or indication (e.g., anti-inflammatory, anticancer, antiviral)
- Formulation specifics (e.g., dosage form, release mechanism)
The breadth of the claims will depend on whether they cover:
- Structure-based claims only, which provide narrow but enforceable protection
- Use claims—covering methods of treatment, which can be broader if well-claimed
- Formulation claims—covering physical compositions
3. Claim Breadth and Potential Limitations
The enforceability and commercial scope hinge on the claim language:
- Narrow claims: Focused on specific chemical structures or particular uses, reducing risk of invalidation but limiting scope
- Broad claims: Encompass wider chemical classes, use indications, or formulations, offering broader protection but facing higher scrutiny for novelty and inventive step
Given typical patent drafting strategies, a balance is struck between these, possibly with dependent claims narrowing the scope for specific embodiments and a broad independent claim covering a key inventive concept.
4. Likelihood of Novelty and Inventive Step
The novelty hinges on existing prior art—particularly patents, scientific literature, or known compounds. Since the patent was granted, the applicant demonstrated that the claimed subject matter was non-obvious and distinguishable over prior art, yet the claims may be susceptible to challenge if similar compounds or uses exist.
Patent Landscape and Enforceability
1. Patent Family and Extension Strategy
DK1791542's family members (if any) expand protection to other jurisdictions, such as the European Patent Office (EPO), US, Japan, or China. Extended coverage enhances commercial leverage, particularly for global pharmaceuticals.
2. Overlap with Prior Art and Competitors
The patent landscape in the relevant therapeutic area may include overlapping patents, especially if the invention pertains to known classes of compounds like kinase inhibitors, monoclonal antibodies, or nucleic acid-based therapies.
3. Litigation and Infringement Risks
The strength of the patent in enforcement depends on claim clarity, prior art, and judicial interpretations. European jurisdictions, including Denmark, tend toward strict scrutiny of claim validity and infringement.
Strategic Implications and Market Positioning
1. Competitive Edge
A patent with narrowly tailored claims secures exclusive rights over a specific compound or use, blocking generic or biosimilar entry. Broad claims offer expansive market protection but necessitate robust inventive step arguments.
2. Licensing and Collaborations
The scope determines licensing opportunities. Narrow claims may limit partnerships but afford targeted exclusivities, while broader claims can attract licensees interested in wider coverage.
3. Lifecycle Management
The patent's lifespan influences patent strategies, including extensions, supplementary protection certificates (SPCs), or combination patents to prolong market exclusivity.
Conclusion
DK1791542 exemplifies a strategically drafted pharmaceutical patent, balancing claim breadth with defensibility. While precise claim wording is vital—potentially determined through patent documents and legal proceedings—the general principles suggest a focus on a novel pharmaceutical compound or use that provides meaningful market exclusivity. Stakeholders should monitor related patent filings, ongoing litigation, and market developments to optimize their positioning around this patent.
Key Takeaways
-
In-Depth Claim Review is Essential: The patent's value depends on the precise scope, requiring detailed claim analysis to identify enforceability and potential infringement risks.
-
Strategic Patent Portfolio Management: Combining DK1791542 with broader or related patents enhances competitive leverage and life cycle management.
-
Landscape Vigilance: Regular monitoring of existing and emerging patents in the therapeutic area is vital to avoid infringement and identify licensing opportunities.
-
Cross-Jurisdictional Considerations: Expanding protection through family members in other jurisdictions is critical for global commercialization.
-
Legal and Technical Due Diligence: Assess the patent's strength through expert legal opinions and technical assessments to inform licensing, litigation, or R&D decisions.
FAQs
Q1: What is the typical scope of claims in Danish pharmaceutical patents like DK1791542?
A: They commonly balance between narrow structure-specific claims for enforceability and broader use or formulation claims to maximize market coverage, aligning with international best practices.
Q2: How does the patent landscape affect the commercial potential of DK1791542?
A: Overlapping patents or prior art can limit enforceability, so understanding the patent landscape helps anticipate challenges, license opportunities, or risks of infringement.
Q3: Can DK1791542 be extended to other jurisdictions?
A: Yes, through patent family extensions like EPO or national applications, which increase territorial protection and commercial reach.
Q4: What challenges might arise in defending the claims of DK1791542?
A: Challenges include prior art invalidation, claim construction disputes, or challenges to inventive step, especially if similar compounds are publicly disclosed.
Q5: How can companies leverage the scope of DK1791542 effectively?
A: By designing around narrow claims with supplementary patents, licensing the core invention, or pursuing patent term extensions, companies can maximize strategic value.
References
[1] WIPO Patent Database, DK1791542
[2] EPO and European Patent Office guidelines, 2022
[3] European Patent Convention, Articles on Patentability and Claim Drafting
[4] Patent landscape reports for therapeutic area (specific to the pharmaceutical class involved)
[5] Legal analyses of Danish patent enforcement trends
Note: For precise claim language and legal status, consulting the official patent documents and legal counsel is recommended.
